Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

36.9%

24 terminated/withdrawn out of 65 trials

Success Rate

56.4%

-30.1% vs industry average

Late-Stage Pipeline

83%

54 trials in Phase 3/4

Results Transparency

13%

4 of 31 completed trials have results

Key Signals

1 recruiting4 with results20 withdrawn

Enrollment Performance

Analytics

Phase 3

53(82.8%)

N/A

5(7.8%)

Phase 2

4(6.3%)

Phase 4

1(1.6%)

Phase 1

1(1.6%)

64Total

Phase 3(53)

N/A(5)

Phase 2(4)

Phase 4(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (65)

Showing 20 of 65 trials

NCT07529977Phase 3Not Yet Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

Role: lead

NCT07303322Phase 3Not Yet Recruiting

Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)

Role: lead

NCT07318350Phase 3Not Yet Recruiting

Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA)

Role: lead

NCT06715462Phase 3Withdrawn

Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy

Role: lead

NCT05209984Phase 3Withdrawn

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

Role: lead

NCT07057479Phase 3Withdrawn

Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin

Role: lead

NCT05637710Phase 3Withdrawn

Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil

Role: lead

NCT06560333Phase 3Withdrawn

iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)

Role: lead

NCT05735431Phase 3Withdrawn

Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil

Role: lead

NCT05118672Phase 3Completed

Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment

Role: lead

NCT06731062Not ApplicableCompleted

Assessment of EF192A Potential Sensitization and Accumulated and Primary Irritability in Controlled/Maximized Conditions

Role: lead

NCT07018557Phase 4Recruiting

Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN)

Role: collaborator

NCT01191450Phase 3Completed

Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension

Role: lead

NCT01167010Phase 3Completed

A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma

Role: lead

NCT03936218Phase 3Completed

Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

Role: lead

NCT05214911Phase 3Completed

Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children

Role: lead

NCT05876546Not ApplicableCompleted

Evaluation of Skin Irritancy and Sensitization of a Liquid Bandage

Role: lead

NCT05888311Not ApplicableCompleted

Evaluation of the Protection of a Liquid Bandage

Role: lead

NCT03835325Not ApplicableCompleted

The Effect of a Multivitamin in the Treatment of Memory Loss in Postmenopausal Women

Role: lead

NCT06905210Phase 3Not Yet Recruiting

Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

Role: lead